MediciNova, Inc. (MNOV)

MediciNova Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-8.41	-8.57	-14.07	-10.13	-13.85	-12.94
Depreciation & Amortization	0.22	0.21	0.21	0.24	0.23	0.02
Share-Based Compensation	0.52	0.71	0.64	1.72	3.18	4.11
Other Operating Activities	-0.45	0.21	0.3	-1.21	-0.38	-0.32
Operating Cash Flow	-8.12	-7.43	-12.91	-9.38	-10.83	-9.12
Capital Expenditures	-0.02	-0.02	-0.01	-0.03	-0.04	-0.01
Change in Investments	0	39.93	-40	0	0	0
Investing Cash Flow	-0.02	39.91	-40.01	-0.03	-0.04	-0.01
Share Issuance / Repurchase	0	0	0.01	20.78	7.11	10.62
Financing Cash Flow	0	0	0.01	20.78	7.11	10.62
Exchange Rate Effect	0.02	0.02	-0.02	0.03	0	-0
Net Cash Flow	-8.12	32.49	-52.93	11.39	-3.76	1.48
Free Cash Flow	-8.14	-7.45	-12.92	-9.41	-10.86	-9.14
Free Cash Flow Margin	-814.32%	-745.23%	-	-233.07%	-	-
Free Cash Flow Per Share	-0.17	-0.15	-0.26	-0.19	-0.24	-0.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).